Overhaul of UK medicines legislation gets under way
This article was originally published in SRA
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency has begun a three-year project to consolidate and review the national medicines legislation1. The Medicines Act 1968 has been expanded and changed so many times over the past 40 years that it is now a “very complex and fragmented set of legal provisions which are unwieldy to use and complicated to explain or understand”, says the agency. Some of the provisions may no longer be fit for purpose and may contradict current European Union-driven regulation, it adds.